D.A. Davidson & Co.
- SEC CIK
- 0001080107
- Latest filing
- Jul 24, 2026
AZN holding history
AstraZeneca PLC in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AZN overviewAll 13F holders of AZNFull Q2 2026 holdings
- Shares (Q2 2026)
- 30,619
- Value
- $5.81M
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 30,619 | $5.81M | <0.1% | +8,198+36.6% | Added | Holders |
| Q1 2026 | 22,421 | $4.42M | <0.1% | +10,263+84.4% | AddedConverted for a 1-for-2 split | Holders |
| Q4 2025 | 24,317 | $2.24M | <0.1% | −6,157−20.2% | Reduced | Holders |
| Q3 2025 | 30,474 | $2.34M | <0.1% | −6,689−18.0% | Reduced | Holders |
| Q2 2025 | 37,163 | $2.60M | <0.1% | +1,109+3.1% | Added | Holders |
| Q1 2025 | 36,054 | $2.65M | <0.1% | −62−0.2% | Reduced | Holders |
| Q4 2024 | 36,116 | $2.37M | <0.1% | +10,257+39.7% | Added | Holders |
| Q3 2024 | 25,859 | $2.01M | <0.1% | −7,835−23.3% | Reduced | Holders |
| Q2 2024 | 33,694 | $2.63M | <0.1% | +2,935+9.5% | Added | Holders |
| Q1 2024 | 30,759 | $2.08M | <0.1% | −753−2.4% | Reduced | Holders |
| Q4 2023 | 31,512 | $2.12M | <0.1% | +6,279+24.9% | Added | Holders |
| Q3 2023 | 25,233 | $1.71M | <0.1% | +1,813+7.7% | Added | Holders |
| Q2 2023 | 23,420 | $1.68M | <0.1% | −56−0.2% | Reduced | Holders |
| Q1 2023 | 23,476 | $1.63M | <0.1% | −1,646−6.6% | Reduced | Holders |
| Q4 2022 | 25,122 | $1.71M | <0.1% | +387+1.6% | Added | Holders |
| Q3 2022 | 24,735 | $1.36M | <0.1% | +3,254+15.1% | Added | Holders |
| Q2 2022 | 21,481 | $1.42M | <0.1% | +1,752+8.9% | Added | Holders |
| Q1 2022 | 19,729 | $1.31M | <0.1% | +758+4.0% | Added | Holders |
| Q4 2021 | 18,971 | $1.11M | <0.1% | −613−3.1% | Reduced | Holders |
| Q3 2021 | 19,584 | $1.18M | <0.1% | +1,865+10.5% | Added | Holders |
| Q2 2021 | 17,719 | $1.06M | <0.1% | +1,096+6.6% | Added | Holders |
| Q1 2021 | 16,623 | $827.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.